NASDAQ:BSX

Boston Scientific (BSX) stock price edges up after selloff; Farapulse data and March 28 CHAMPION-AF readout in focus

Shares of Boston Scientific Corp rose about 0.7% to $74.61 in early afternoon trading on Tuesday, after a choppy start to the week. About 9.1 million shares had traded by 1:15 p.m. in New York.

10 February 2026

Earnings Reports·NASDAQ:BSX·Stock Market

Boston Scientific stock price steadies after historic plunge as investors zero in on heart-rhythm outlook

Boston Scientific shares edged down 0.2% to $77.49 in late-morning trading Friday, following a wild two-day rollercoaster that has investors scrambling for insight into the medical-device company’s growth drivers.

6 February 2026

NASDAQ:BSX·Stock Market

Boston Scientific stock price climbs as Penumbra deal stays in focus ahead of Feb. 4 earnings

Boston Scientific shares climbed 1.7% to $93.87 on Friday afternoon, rebounding from an earlier dip to $91.72.

30 January 2026

Earnings Reports·NASDAQ:BSX·NASDAQ:PEN·Stock Market

Boston Scientific stock flat after Nalu buy closes; BSX investors eye Feb. 4 earnings

Shares of Boston Scientific Corporation held steady Tuesday following the completion of its acquisition of Nalu Medical. By 2:43 p.m. ET, the stock dipped just 0.01%, trading at $93.54.

27 January 2026

Earnings Reports·NASDAQ:BSX·Stock Market

Boston Scientific stock rises as Evercore taps BSX for a tactical list ahead of earnings

Shares of Boston Scientific Corp climbed 1.7% to $94.12 Monday afternoon, gaining $1.61 since Friday’s close. The stock fluctuated between $92.03 and $94.24, with roughly 5.4 million shares traded by mid-afternoon.

26 January 2026

Earnings Reports·NASDAQ:BSX·Stock Market

Boston Scientific stock price: BSX ends higher as Fitch turns credit outlook positive ahead of key catalysts

Shares of Boston Scientific Corp ended Friday up 1.3% at $92.51. Late in the session, Fitch Ratings revised the medical-device maker’s outlook to Positive, while keeping its A- and F1 issuer ratings unchanged. Fitch noted this could pave the way for an upgrade to “A” once the company’s financials stabilize following its planned Penumbra acquisition. The agency also highlighted leverage peaking near 3.3 times by the end of 2026 based on its projections.

24 January 2026

NASDAQ:BSX·Stock Market

Boston Scientific stock steadies after FDA flags AXIOS stent issue; Penumbra deal still in play

Shares of Boston Scientific Corporation held steady, edging just above $91.20 during late morning trading in New York on Wednesday.

21 January 2026

NASDAQ:BSX·NASDAQ:PEN·Stock Market

Intuitive Surgical stock: Bernstein lifts ISRG target as JPM conference week begins

Bernstein bumped up its price target on Intuitive Surgical to $740 from $700, maintaining an “Outperform” rating. The robotic surgery firm’s shares closed Friday up 0.2% at $586.24, after trading between $579.62 and $589.58. Its 52-week range stands at $425 to $616.

11 January 2026

NASDAQ:BSX·NASDAQ:ISRG·NYSE:SYK·Stock Market

Boston Scientific (BSX) stock slips in year-end pullback; February earnings loom

Boston Scientific shares closed down 0.3% at $95.76 on Monday. The stock traded between $95.53 and $96.64, with about 5.4 million shares changing hands. StockAnalysis

30 December 2025

Earnings Reports·NASDAQ:BSX·Stock Market

NASDAQ:BSX 30 December 2025 - 10 February 2026